Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series

By  

Case Reports in Neurology, Vol. 8, Iss. 1, 2016-01 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

By PALDINO M J   DESJARDINS A   FRIEDMAN H S   VREDENBURGH J J   BARBORIAK D P  

British Journal of Radiology, Vol. 85, Iss. 1012, 2012-04 ,pp. : 382-389

British Institute of Radiology

Access to resources Recommend Favorite

High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On

By Montagnani Marco   Giandinoto Marina   Lisotti Andrea   Galli Silvia   Azzaroli Francesco   Buonfiglioli Federica   Turco Laura   Aldini Rita   Mazzella Giuseppe  

Digestive Diseases and Sciences, Vol. 57, Iss. 2, 2012-02 ,pp. : 561-567

Springer Publishing Company

Access to resources Recommend Favorite

Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa

By Wang Yun-Xia   Zheng Shu-Mei   Zhang Yong   Qin Jian-Ping   Lin Hang   Liu Xiao-Cong   Shen Cai-Fei   Jiang Ming-De  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 2, 2013-02 ,pp. : 213-217

Informa Healthcare

Access to resources Recommend Favorite

Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B

By  

Digestion, Vol. 87, Iss. 3, 2013-05 ,pp. : 196-203

Karger

Access to resources Recommend Favorite